Articles tagged "Risk factors"

2020 American Transplant Congress
Is it Safe to Use Organs from Deceased Donor with Open Abdomen?
G. El-Gazzaz, A. L. Friedman
Live On New York, New York, NY
*Purpose: The shortage of organs supplies and increased number of waiting patients for organs transplantation allowed to review historical contraindication for donation. Due to limited…
2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Active Heavy Smoking or Intermittent Drug Abuse
Z. Arabi¹, A. Hamad², S. Kaysi³, M. Bukhari⁴
¹KAMC, Riyadh, Saudi Arabia, ²The Regional Medical Center, Orangeburg, SC, ³CHU Clermont-Ferrand, Saint Pryv/ Saint Mesmin, France, ⁴Taif University, Taif, Saudi Arabia
*Purpose: Potential kidney donors who actively smoke heavily or had intermittent illegal drug use (IIDU) are mostly excluded from donating a kidney. Tobacco use in…
2020 American Transplant Congress
Exploring Psychosocial Factors and Disparity in Liver Transplant
K. Schmidt
Dept. of Psychiatry & Behavioral Sciences, Emory University, Atlanta, GA
*Purpose: Trends in liver transplant (LT) have shifted, and increasingly, individuals with alcohol liver disease (ALD) are receiving LT without 6-months of sobriety (Lee &…
2020 American Transplant Congress
Peri-Operative Extracorporeal Photopheresis in High Risk Patients after Heart Transplantation
A. Zuckermann¹, J. Gökler¹, N. Worel², P. Angleitner¹, E. Ceran¹, E. Ceran¹, N. Neuber¹, P. Kaiser¹, G. Laufer¹, A. Aliabadi-Zuckermann¹
¹Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria, ²Department of Transfusion Medicine, Medical University of Vienna, Vienna, Austria
*Purpose: Extracorporeal photopheresis (ECP) is an established therapy for treatment of heart transplant rejection and is also applied for rejection prevention in the perioperative setting…
2020 American Transplant Congress
Characteristics of Early BK Viremia after Renal Transplantation at an Urban Academic Medical Center
K. Kurzweil, K. Lamartina, K. Svaflarska, D. Kutrzuba, N. Fayyaz, O. Piatek, P. West-Thielke, Z. Hajjiri, I. Tzvetanov, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: BK viremia (BKV) is a deleterious complication after renal transplantation that can compromise allograft function. Centers face the challenge of identifying at-risk patients and…
2020 American Transplant Congress
Outcomes Associated with Mycophenolate Weight-Based Dosing in Varying Immunologic Risk Kidney Transplant Recipients
A. A. Al-Bahou, A. R. Webb, M. Bloxam, L. J. Bowman Anger, R. S. Baliga, A. J. Brueckner
Tampa General Hospital, Tampa, FL
*Purpose: Mycophenolate acid (MPA) is traditionally dosed in kidney transplant recipients (KTR) using the FDA-approved fixed dosing which is irrespective of patient-specific variables such as…
2020 American Transplant Congress
Risk Factors for Incisional Hernia Recurrence and Surgical Site Infection in the Transplant Population
O. Andacoglu¹, U. Ozbek², F. Cheema¹, L. Sanchez¹, F. Malcher¹
¹General Surgery, Montefiore Medical Center, Bronx, NY, ²Population Health Science and Policy, Icahn School of Medicine Mount Sinai, New York, NY
*Purpose: To investigate recurrence and surgical site infection (SSI) rates and risk factors after incisional hernia (IH) repair following abdominal transplantation.*Methods: A retrospective review of…
2020 American Transplant Congress
Multi- National Survey among Nephrologists and Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Family History of Kidney Disease
Z. Arabi¹, S. Kaysi², A. Altheaby¹, E. Elhassan¹, M. Bukhari³, A. Mateen¹, A. Hamad⁴
¹KAMC, Riyadh, Saudi Arabia, ²CHR Orleans, Orleans, France, ³Taif University, Taif, Saudi Arabia, ⁴The Regional Medical Center, Orangeburg, SC
*Purpose: Kidney transplantation from a living donor is the best treatment option for End Stage Kidney Disease. Considering the shortage of available organs, transplant centers…
2020 American Transplant Congress
Effects of BMI on Kidney Transplant Outcomes are Highly Modified by Patient and Donor Characteristics
J. Schold¹, J. Augustine², A. Huml², R. Fatica², S. Nurko², A. Wee³, E. Poggio²
¹Cleveland Clinic Foundation, Cleveland, OH, ²Nephrology, Cleveland Clinic Foundation, Cleveland, OH, ³Surgery, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Body Mass Index (BMI) is a well-established risk factor for transplant outcomes and high BMI is a commonly used relative contradiction for used for…
2020 American Transplant Congress
Kidney Transplant from Sickle Cell Donors
P. Vaitla, F. H. Cabeza Rivera, W. Cheungpasitporn, F. Koller, P. Matemavi, J. Wynn
University of Mississippi, Jackson, MS
*Purpose: Patients with End-stage renal disease have an increased risk of death. Dialysis and kidney transplantation are the only treatments. Patients who receive kidney transplantation…